Active Ingredient History
Mumps vaccines are vaccines which prevent mumps. When given to a majority of the population they decrease complications at the population level. Effectiveness when 90% of a population is vaccinated is estimated at 85%. Two doses are required for long term prevention. The initial dose is recommended between 12 and 18 months of age. The second dose is then typically given between two years and six years of age. Usage after exposure in those not already immune may be useful. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Acute-Phase Reaction (Phase 2/Phase 3)
Arthritis, Juvenile (Phase 4)
Bacterial Infections (Phase 3)
Chickenpox (Phase 4)
Chikungunya Fever (Phase 2)
Communicable Diseases (Phase 2)
Condylomata Acuminata (Phase 3)
COVID-19 (Phase 4)
Dengue (Phase 3)
Diphtheria (Phase 3)
Diphtheria Toxoid (Phase 2)
Eczema (Phase 4)
Encephalitis, Japanese (Phase 3)
Esophageal and Gastric Varices (Phase 2)
Haemophilus influenzae (Phase 2)
Haemophilus influenzae type b (Phase 3)
Healthy Volunteers (Phase 3)
Hepatitis A (Phase 4)
Hepatitis B (Phase 2)
HIV (Phase 4)
HIV Infections (Phase 2)
Human papillomavirus 16 (Phase 4)
Hypersensitivity (Phase 4)
Immune System Diseases (Phase 4)
Infections (Phase 4)
Measles (Phase 4)
Measles-Mumps-Rubella Vaccine (Phase 4)
Meningitis (Phase 3)
Meningitis, Meningococcal (Phase 3)
Meningococcal Infections (Phase 3)
Mumps (Phase 4)
Mumps Vaccine (Phase 2)
Neisseria meningitidis (Phase 3)
Papillomavirus Infections (Phase 4)
Pertussis Vaccine (Phase 3)
Pneumococcal Infections (Phase 3)
Pneumococcal Vaccines (Phase 3)
Poliomyelitis (Phase 4)
Poliovirus Vaccines (Phase 2)
Psoriasis (Phase 1)
Respiratory Tract Infections (Phase 4)
Rotavirus (Phase 4)
Rubella (Phase 4)
Rubella Vaccine (Phase 2)
Severe Dengue (Phase 3)
Systemic Inflammatory Response Syndrome (Phase 3)
Tetanus (Phase 3)
Vaccines (Phase 4)
Virus Diseases (Phase 3)
Warts (Phase 4)
Whooping Cough (Phase 3)
Yellow Fever (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue